GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Gross Margin %

PharmaTher Holdings (XCNQ:PHRM) Gross Margin % : 0.00% (As of Aug. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PharmaTher Holdings's Gross Profit for the three months ended in Aug. 2024 was C$0.00 Mil. PharmaTher Holdings's Revenue for the three months ended in Aug. 2024 was C$0.00 Mil. Therefore, PharmaTher Holdings's Gross Margin % for the quarter that ended in Aug. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for PharmaTher Holdings's Gross Margin % or its related term are showing as below:


XCNQ:PHRM's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.565
* Ranked among companies with meaningful Gross Margin % only.

PharmaTher Holdings had a gross margin of N/A% for the quarter that ended in Aug. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for PharmaTher Holdings was 0.00% per year.


PharmaTher Holdings Gross Margin % Historical Data

The historical data trend for PharmaTher Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Gross Margin % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Gross Margin %
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Gross Margin %

For the Biotechnology subindustry, PharmaTher Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Gross Margin % falls into.



PharmaTher Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

PharmaTher Holdings's Gross Margin for the fiscal year that ended in May. 2023 is calculated as

Gross Margin % (A: May. 2023 )=Gross Profit (A: May. 2023 ) / Revenue (A: May. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

PharmaTher Holdings's Gross Margin for the quarter that ended in Aug. 2024 is calculated as


Gross Margin % (Q: Aug. 2024 )=Gross Profit (Q: Aug. 2024 ) / Revenue (Q: Aug. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PharmaTher Holdings  (XCNQ:PHRM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PharmaTher Holdings had a gross margin of N/A% for the quarter that ended in Aug. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


PharmaTher Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings Headlines

No Headlines